Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
NCT07021937Phase 3Not yet recruiting
A Phase 3 trial of semaglutide in obesity, sponsored by University of Colorado Denver. Planned start Jun 2026; status: not yet recruiting.
Beyond the preview
Study design, results and competitive context are available in the Gosset platform where reported.
Available in the Gosset platform where reported.
Available in the Gosset platform where reported.
See how Gosset can support your research on NCT07021937.